Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penson

Showing results (411-420 of 1,177) with videos related to

Pageof 118
Sort By:
Archives of Medical Science : AMS|September 15, 2021
Statins as anti-pyroptotic agentsMasoomeh Khalifeh, Peter E Penson, Maciej Banach, et al.
Nature Clinical Practice. Urology|August 12, 2006
Discussing quality-of-life issues with a patient newly diagnosed with prostate cancerJohn L Gore, David F Penson, Mark S Litwin
European Heart Journal|May 14, 2022
Extreme cardiovascular risk-do we need a new risk category?Krzysztof Dyrbuś, Mariusz Gąsior, Peter E Penson, et al.
Thrombosis and Haemostasis|September 30, 2019
Warfarin Therapy and Improved Anticoagulation Control by Patient Self-ManagementLeona A Ritchie, Peter E Penson, Deirdre A Lane
Clinical Advances in Hematology & Oncology : H&O|May 12, 2011
Emerging therapeutic options for platinum-sensitive ovarian cancer patientsDeborah K Armstrong, Robert L Coleman, Richard T Penson
The Oncologist|June 1, 2004
Too old to care?Richard T Penson, Kristy J Daniels, Thomas J Lynch
Psycho-Oncology|September 24, 2004
Differences in health-related quality of life of prostate cancer patients based on stage of cancerBarry Rosenfeld, Andrew J Roth, Sanjay Gandhi, et al.
Annals of Internal Medicine|September 13, 2013
Effect of age, tumor risk, and comorbidity in a u.s. Population-based cohort of men with prostate cancerTimothy J Daskivich, Mark S Litwin, David F Penson
Pediatrics|May 22, 2013
Effectiveness of hormonal and surgical therapies for cryptorchidism: a systematic reviewDavid Penson, Shanthi Krishnaswami, Astride Jules, et al.
Pediatrics|May 22, 2013
Magnetic resonance imaging for locating nonpalpable undescended testicles: a meta-analysisShanthi Krishnaswami, Christopher Fonnesbeck, David Penson, et al.
Pageof 118

Showing results (411-420 of 1,177) with videos related to

Sort By:
Pageof 118
Archives of Medical Science : AMS|September 15, 2021
Statins as anti-pyroptotic agentsMasoomeh Khalifeh, Peter E Penson, Maciej Banach, et al.
Nature Clinical Practice. Urology|August 12, 2006
Discussing quality-of-life issues with a patient newly diagnosed with prostate cancerJohn L Gore, David F Penson, Mark S Litwin
European Heart Journal|May 14, 2022
Extreme cardiovascular risk-do we need a new risk category?Krzysztof Dyrbuś, Mariusz Gąsior, Peter E Penson, et al.
Thrombosis and Haemostasis|September 30, 2019
Warfarin Therapy and Improved Anticoagulation Control by Patient Self-ManagementLeona A Ritchie, Peter E Penson, Deirdre A Lane
Clinical Advances in Hematology & Oncology : H&O|May 12, 2011
Emerging therapeutic options for platinum-sensitive ovarian cancer patientsDeborah K Armstrong, Robert L Coleman, Richard T Penson
The Oncologist|June 1, 2004
Too old to care?Richard T Penson, Kristy J Daniels, Thomas J Lynch
Psycho-Oncology|September 24, 2004
Differences in health-related quality of life of prostate cancer patients based on stage of cancerBarry Rosenfeld, Andrew J Roth, Sanjay Gandhi, et al.
Annals of Internal Medicine|September 13, 2013
Effect of age, tumor risk, and comorbidity in a u.s. Population-based cohort of men with prostate cancerTimothy J Daskivich, Mark S Litwin, David F Penson
Pediatrics|May 22, 2013
Effectiveness of hormonal and surgical therapies for cryptorchidism: a systematic reviewDavid Penson, Shanthi Krishnaswami, Astride Jules, et al.
Pediatrics|May 22, 2013
Magnetic resonance imaging for locating nonpalpable undescended testicles: a meta-analysisShanthi Krishnaswami, Christopher Fonnesbeck, David Penson, et al.
Pageof 118